Kim L. Isaacs

7.7k total citations · 1 hit paper
95 papers, 3.9k citations indexed

About

Kim L. Isaacs is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Kim L. Isaacs has authored 95 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Genetics, 35 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in Kim L. Isaacs's work include Inflammatory Bowel Disease (53 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (8 papers). Kim L. Isaacs is often cited by papers focused on Inflammatory Bowel Disease (53 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (8 papers). Kim L. Isaacs collaborates with scholars based in United States, Canada and United Kingdom. Kim L. Isaacs's co-authors include Bruce E. Sands, Edward V. Loftus, Gary R. Lichtenstein, Miguel Regueiro, Lauren B. Gerson, Hans Herfarth, R. Balfour Sartor, Stephen Haskill, David M. Warshauer and Millie D. Long and has published in prestigious journals such as Gastroenterology, Neurology and Cancer Research.

In The Last Decade

Kim L. Isaacs

89 papers receiving 3.8k citations

Hit Papers

ACG Clinical Guideline: Management of Crohn's Disease in ... 2018 2026 2020 2023 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim L. Isaacs United States 29 2.3k 1.5k 1.3k 654 521 95 3.9k
Mollie Ferris Canada 4 2.5k 1.1× 1.7k 1.1× 1.4k 1.1× 678 1.0× 785 1.5× 7 4.1k
Timothy R. Orchard United Kingdom 24 2.7k 1.2× 2.0k 1.3× 1.1k 0.9× 761 1.2× 538 1.0× 51 4.0k
Alfredo Papa Italy 36 1.9k 0.8× 1.4k 0.9× 1.4k 1.1× 673 1.0× 493 0.9× 161 3.9k
Gottfried Novacek Austria 26 1.8k 0.8× 1.6k 1.0× 1.2k 0.9× 387 0.6× 418 0.8× 103 3.3k
Eugeni Domènech Spain 36 2.5k 1.1× 2.2k 1.5× 1.2k 1.0× 598 0.9× 329 0.6× 222 4.0k
Stuart Bloom United Kingdom 27 2.4k 1.1× 1.6k 1.0× 1.3k 1.0× 1.2k 1.8× 583 1.1× 114 4.4k
Rami Eliakim Israel 28 2.4k 1.1× 1.7k 1.1× 1.4k 1.1× 370 0.6× 500 1.0× 83 3.9k
Greg Chernoff United States 5 2.5k 1.1× 1.7k 1.1× 1.4k 1.1× 679 1.0× 794 1.5× 9 4.1k
Ing Shian Soon Canada 8 2.7k 1.2× 1.8k 1.2× 1.3k 1.0× 733 1.1× 807 1.5× 15 4.1k
Lene Riis Denmark 31 2.0k 0.9× 1.6k 1.0× 1.0k 0.8× 576 0.9× 506 1.0× 90 3.3k

Countries citing papers authored by Kim L. Isaacs

Since Specialization
Citations

This map shows the geographic impact of Kim L. Isaacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim L. Isaacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim L. Isaacs more than expected).

Fields of papers citing papers by Kim L. Isaacs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim L. Isaacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim L. Isaacs. The network helps show where Kim L. Isaacs may publish in the future.

Co-authorship network of co-authors of Kim L. Isaacs

This figure shows the co-authorship network connecting the top 25 collaborators of Kim L. Isaacs. A scholar is included among the top collaborators of Kim L. Isaacs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim L. Isaacs. Kim L. Isaacs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunt, Daniel, et al.. (2024). Skin health of urban-living Aboriginal children attending a primary care Aboriginal Community Controlled Health Organisation clinic. Australian Journal of General Practice. 53(11 Suppl). S115–S122. 1 indexed citations
2.
Chen, Bing, Craig Mowat, Kim L. Isaacs, et al.. (2022). Inflammatory Bowel Disease and Cardiovascular Diseases. The American Journal of Medicine. 135(12). 1453–1460. 46 indexed citations
3.
Hudson, Joshua, Edward L. Barnes, Hans Herfarth, Kim L. Isaacs, & Animesh Jain. (2018). Bariatric Surgery Is a Safe and Effective Option for Patients with Inflammatory Bowel Diseases: A Case Series and Systematic Review of the Literature. Inflammatory Intestinal Diseases. 3(4). 173–179. 24 indexed citations
4.
Weaver, Kimberly N., Martin Gregory, Gaurav Syal, et al.. (2018). Ustekinumab Is Effective for the Treatment of Crohn’s Disease of the Pouch in a Multicenter Cohort. Inflammatory Bowel Diseases. 25(4). 767–774. 59 indexed citations
5.
Iskandar, Heba, Julia B. Greer, Alyssa M. Krasinskas, et al.. (2017). IBD LIVE Series—Case 8. Inflammatory Bowel Diseases. 23(10). 1667–1677. 2 indexed citations
6.
Herfarth, Hans, Susan Jackson, Christopher Martin, et al.. (2016). Investigator-Initiated IBD Trials in the United States. Inflammatory Bowel Diseases. 23(1). 14–22. 17 indexed citations
9.
Herfarth, Hans, Millie D. Long, & Kim L. Isaacs. (2012). Methotrexate: Underused and Ignored?. Digestive Diseases. 30(Suppl. 3). 112–118. 17 indexed citations
10.
Bassaganya‐Riera, Josep, Raquel Hontecillas, William Horne, et al.. (2012). Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease. Clinical Nutrition. 31(5). 721–727. 75 indexed citations
11.
Sandborn, William J., S. Hanauer, Douglas C. Wolf, et al.. (2005). Maintenance of Remission over 1 Year in Patients with Active Crohnʼs Disease Treated with Adalimumab. The American Journal of Gastroenterology. 100. S311–S311. 11 indexed citations
12.
Sandborn, William J., Stephen B. Hanauer, Douglas C. Wolf, et al.. (2005). Remission and Clinical Response Induced and Maintained in Patients with Active Crohnʼs Disease Treated for 1-Year Open-Label with Adalimumab. The American Journal of Gastroenterology. 100. S316–S317. 4 indexed citations
13.
Sandborn, William J., Daniel H. Present, Kim L. Isaacs, et al.. (2003). Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial. Gastroenterology. 125(2). 380–388. 227 indexed citations
14.
Isaacs, Kim L.. (2002). Upper gastrointestinal tract endoscopy in inflammatory bowel disease. Gastrointestinal Endoscopy Clinics of North America. 12(3). 451–462. 18 indexed citations
15.
Isaacs, Kim L.. (1998). Severe bone pain as an adverse effect of cyclosporin therapy for Crohn's disease. Inflammatory Bowel Diseases. 4(2). 95–97. 10 indexed citations
16.
Boerner, Ryan, Daniel B. Fried, David M. Warshauer, & Kim L. Isaacs. (1996). Pneumatosis intestinalis. Digestive Diseases and Sciences. 41(11). 2272–2285. 78 indexed citations
17.
Moore, G. P. M., et al.. (1995). Estimating densities of original and derived secondary wool follicles in the sheep.. Wool technology and sheep breeding. 43(4). 2 indexed citations
18.
Isaacs, Kim L., K. P. McNatty, Louise Shaw, et al.. (1995). Plasma FSH, LH and immunoreactive inhibin concentrations in FecBB/FecBB and FecB+/FecB+ Booroola ewes and rams from birth to 12 months of age. Reproduction. 103(1). 89–97. 17 indexed citations
19.
Isaacs, Kim L., et al.. (1991). Influence of maternal liveweight on reproductive performance and wool production of heterozygous Booroola Merino × Coopworth (Fec B Fec + ) and Merino × Coopworth ewes. New Zealand Journal of Agricultural Research. 34(1). 55–67. 5 indexed citations
20.
Isaacs, Kim L. & Frederick W. Miller. (1983). Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexes.. PubMed Central. 111(3). 298–306. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026